UA93814U - A method for diagnosing syndrome of retardation of fetus development and the degree of its severity - Google Patents

A method for diagnosing syndrome of retardation of fetus development and the degree of its severity

Info

Publication number
UA93814U
UA93814U UAU201406263U UAU201406263U UA93814U UA 93814 U UA93814 U UA 93814U UA U201406263 U UAU201406263 U UA U201406263U UA U201406263 U UAU201406263 U UA U201406263U UA 93814 U UA93814 U UA 93814U
Authority
UA
Ukraine
Prior art keywords
concentration
weeks
degree
vegf
retardation
Prior art date
Application number
UAU201406263U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Микола Олександрович Щербина
Михайло Васильович Макаренко
Original Assignee
Харківський Національний Медичний Університет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківський Національний Медичний Університет filed Critical Харківський Національний Медичний Університет
Priority to UAU201406263U priority Critical patent/UA93814U/en
Publication of UA93814U publication Critical patent/UA93814U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The method for diagnosing fetal growth retardation and determination of the degree of its severity includes determination in woman's blood of placental dysfunction markers. Determined is the dynamics of changes in concentration of receptor of vascular endothelial growth factor (VEGF-R1) at different stages of pregnancy. At concentration of VEGF-R1 (2,32 ± 0,10) ng / ml at 16-19 weeks, at concentration (2,45 ± 0,18) ng / ml at 20-27 weeks, at concentration of (2,8 ± 0.21) ng / ml at 28-32 weeks, at concentration (4,25 ± 0,16) ng / ml at 33-37 weeks and at concentration (3,92 ± 0,12) ng / ml at 38- 40 weeks with the syndrome of fetal growth retardation (SFGR) of I degree is diagnosed. At concentration of VEGF-R1 (2,88 ± 0,77) ng / ml at 16-19 weeks, at concentration (3,84 ± 0,54) ng / ml at 20-27 weeks, at concentration (8,22 ± 0.66) ng / ml at 28-32 weeks, at concentration (9,86 ± 0,72) ng / ml at 33-37 weeks and at concentration (9,16 ± 0,54) ng / ml at 38- 40 weeks SFGR of II degree is diagnosed. At concentration of VEGF-R1 (4,24 ± 0,62) ng / ml at 16-19 weeks, at concentration (9,92 ± 0,88) ng / mlat 20-27 weeks with concentration of (11,4 ± 0.79) ng / ml at 28-32 weeks and at concentration (10,2 ± 0,76) ng / ml at 33-37 weeks SFGR of III degree is diagnosed.
UAU201406263U 2014-06-06 2014-06-06 A method for diagnosing syndrome of retardation of fetus development and the degree of its severity UA93814U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201406263U UA93814U (en) 2014-06-06 2014-06-06 A method for diagnosing syndrome of retardation of fetus development and the degree of its severity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201406263U UA93814U (en) 2014-06-06 2014-06-06 A method for diagnosing syndrome of retardation of fetus development and the degree of its severity

Publications (1)

Publication Number Publication Date
UA93814U true UA93814U (en) 2014-10-10

Family

ID=56277739

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201406263U UA93814U (en) 2014-06-06 2014-06-06 A method for diagnosing syndrome of retardation of fetus development and the degree of its severity

Country Status (1)

Country Link
UA (1) UA93814U (en)

Similar Documents

Publication Publication Date Title
WO2018208091A3 (en) Biomarker for monitoring or diagnosing onset of liver cancer in high-risk group for liver cancer and use thereof
WO2015157704A3 (en) Methods and compositions for detecting misfolded proteins
WO2014099919A3 (en) Noninvasive detection of fetal aneuploidy in egg donor pregnancies
EP3495502A3 (en) Biomarkers for premature birth
EP3637105A3 (en) Methods for predicting time-to-delivery in pregnant women
EP3492607A3 (en) Urinary mirnas for the in vitro diagnosis of bladder cancer
UA93814U (en) A method for diagnosing syndrome of retardation of fetus development and the degree of its severity
WO2015173430A3 (en) Early placenta insulin-like peptide (pro-epil)
RU2013125276A (en) METHOD FOR PREDICTING PREECLAMPSIA IN PREGNANT WOMEN WITH PLACENTAL INSUFFICIENCY
RU2010148706A (en) METHOD FOR DETERMINING HISTAMINE INCREASE IN PREGNANT BLOOD UNDER INFLUENCE OF ARGININDEHYDROGENASE ACTIVITY GROWTH IN PLACENTA SINCITIOTROFOBLAST CAUSED BY TREASIS AGAINST THREE AREA.
WO2015155523A3 (en) Carrier status of annexin a5 m2 haplotype and obstetric risks
EP2846285A3 (en) Risk stratification of suspected AMI patients
UA131761U (en) METHOD OF PRECLINICAL DIAGNOSIS OF PLACENTAL INSUFFICIENCY IN PREGNANT WOMEN ON THE BACKGROUND OF GESTATIONAL ENDOTHELIOPATHY
UA95701U (en) Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia
UA96344U (en) METHOD OF DIAGNOSIS OF FRUIT Growth Delay Syndrome in Pregnant Women with Placental Dysfunction
UA91252U (en) Method for predicting intrauterine infection of fetus in incomplete pregnancy and premature rupture of fetal membranes
UA125540U (en) METHOD OF PREVENTION OF DEVELOPMENT OF PLACENTAR DYSFUNCTION IN HIV-INFECTED PREGNANCY
UA78016U (en) method for diagnosis of intrauterine fetal placental dysfunction in the III trimester of pregnancy
RU2014146126A (en) METHOD FOR IDENTIFYING RISK GROUPS OF ARTERIAL HYPERTENSION IN WOMEN WITH OBESITY DURING PREGNANCY
UA106446U (en) A method for diagnosing endothelial dysfunction and its correction in patients with acute epididymitis
郭祯 Evaluations on TEM-4 Oral Test
Khan et al. A COMPARISON OF AMERICAN THYROID ASSOCIATION AND CONVENTIONAL CRITERIA: IN EVALUATION OF THYROID HORMONE PROFILE OF CLINICALLY EUTHYROID PREGNANT WOMEN ATTENDING IN A TERTIARY HOSPITAL OF BANGLADESH
Lagarce Medical termination of pregnancy following premature rupture of membranes and oligohydramnios in mother and arthrogryposis in fetus: 2 case reports
杨静 Selection and evaluation of clinical diagnostic cut point of glycated albumin
UA94059U (en) Method for diagnosing fracture healing